Description
Why choose this
The 2.5mg strength is where most people new to tirzepatide begins. It gives your body time to adjust to the medicine and keeps stomach side effects easier to manage. You stay on it for at least four weeks before moving up, and it is not meant to be your long-term dose. Your strength is confirmed after your Velthera assessment and professional review.
Product overview
The Velthera Tirzepatide Pen contains tirzepatide, the same active ingredient as Mounjaro, in a prefilled multi-dose pen. Each pen holds four once-weekly doses, which gives you one month of treatment from a single pen.
Tirzepatide acts on two gut hormone receptors, GIP and GLP-1, which help control appetite and blood sugar. Most people find they feel full sooner and think about food less often, which makes smaller portions easier to keep to.
How to use
Inject once a week on the same day, under the skin of your stomach, thigh or upper arm. Your starting strength and any increases are set after your Velthera assessment and professional review.
Safety
The most common side effects are nausea, diarrhoea, constipation and reduced appetite, mostly when you start or move up a strength. Tirzepatide is not suitable during pregnancy or breastfeeding, or for anyone with a personal or family history of medullary thyroid cancer or MEN2. Tell us about any history of pancreatitis or gallbladder problems during your assessment.
Reviews
There are no reviews yet.